摘要
目的/意义提出生物医学科学数据开放共享的策略性建议,为科学数据可持续发展提供理论支撑。方法/过程采用多案例研究方法,分析英国生物样本库(UK Biobank)、美国国家生物技术信息中心(NCBI)、全球流感共享数据库(GISAID)、Cortellis药物研发情报平台(CDDI)4个国际典型生物医学科学数据平台的开放共享实践。结果/结论基于数据共享前、中、后3个环节提出建议,数据资源建设方面应确定数据权利和权利主体的划分,数据开放使用方面应依据数据属性实行差异化管理,数据生态营造方面应制定促进数据增值的机制和措施。
Purpose/Significance To put forward strategies for the open sharing of biomedical scientific data and provide theoretical support for the sustainable development of scientific data in China.Method/Process The paper adopts the multiple-case study method to analyze open sharing practices of four international typical biomedical scientific data platforms,including UK Biobank,National Center for Biotechnology Information(NCBI),Global Initiative on Sharing All Influenza Data(GISAID)and Cortellis Drug Discovery Intelligence(CDDI).Result/Conclusion Suggestions are proposed based on three processes of before,during and after data sharing.In the construction of data resources,the division of data rights and rights subjects should be determined.The open use of data should be differentiated according to data attributes.In terms of data ecology construction,mechanisms and measures to promote data value-added should be formulated.
作者
万佳林
贾晓峰
胡志民
WAN Jialin;JIA Xiaofeng;HU Zhimin(School of Health Policy and Management,Chinese Academy of Medical Sciences/Peking Union Medical College,Beijing 100730,China;China National Health Development Research Center,Beijing 100044,China)
出处
《医学信息学杂志》
CAS
2024年第2期20-25,共6页
Journal of Medical Informatics
基金
中国医学科学院医学与健康科技创新工程项目(项目编号:2021-I2M-1-057)。